ID   NUCL_RAT                Reviewed;         713 AA.
AC   P13383;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   07-APR-2021, entry version 160.
DE   RecName: Full=Nucleolin;
DE   AltName: Full=Protein C23;
GN   Name=Ncl; Synonyms=Nuc;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2347493; DOI=10.1016/0378-1119(90)90031-l;
RA   Bourbon H.-M., Amalric F.;
RT   "Nucleolin gene organization in rodents: highly conserved sequences within
RT   three of the 13 introns.";
RL   Gene 88:187-196(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-45.
RX   PubMed=2906027; DOI=10.1016/0378-1119(88)90600-2;
RA   Bourbon H.-M., Prudhomme M., Amalric F.;
RT   "Sequence and structure of the nucleolin promoter in rodents:
RT   characterization of a strikingly conserved CpG island.";
RL   Gene 68:73-84(1988).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-145 AND SER-157, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-28; SER-40; SER-41; SER-145;
RP   SER-157; SER-187; SER-213; SER-305; SER-405; SER-566; SER-583 AND SER-622,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Nucleolin is the major nucleolar protein of growing
CC       eukaryotic cells. It is found associated with intranucleolar chromatin
CC       and pre-ribosomal particles. It induces chromatin decondensation by
CC       binding to histone H1. It is thought to play a role in pre-rRNA
CC       transcription and ribosome assembly. May play a role in the process of
CC       transcriptional elongation. Binds RNA oligonucleotides with 5'-UUAGGG-
CC       3' repeats more tightly than the telomeric single-stranded DNA 5'-
CC       TTAGGG-3' repeats (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Identified in a IGF2BP1-dependent mRNP granule complex
CC       containing untranslated mRNAs. Component of the SWAP complex that
CC       consists of NPM1, NCL/nucleolin, PARP1 and SWAP70. Component of a
CC       complex which is at least composed of HTATSF1/Tat-SF1, the P-TEFb
CC       complex components CDK9 and CCNT1, RNA polymerase II, SUPT5H, and
CC       NCL/nucleolin. Interacts with AICDA. Interacts with APTX. Interacts
CC       with C1QBP. Interacts with ERBB4. Interacts (via C-terminus) with FMR1
CC       isoform 6 (via N-terminus). Interacts with GZF1; this interaction is
CC       important for nucleolar localization of GZF1. Interacts with NSUN2.
CC       Interacts with NVL. Interacts (via N-terminus domain) with SETX.
CC       Interacts (via RRM1 and C-terminal RRM4/Arg/Gly-rich domains) with
CC       TERT; the interaction is important for nucleolar localization of TERT.
CC       Interacts with WDR46. Interacts with ZFP36. Interacts with LRRC34.
CC       Interacts with RRP1B. Interacts with HNRNPU; this interaction occurs
CC       during mitosis. Interacts with RIOK1; RIOK1 recruits NCL to PRMT5 for
CC       symmetrically methylation (By similarity). Interacts with ZBTB7B (By
CC       similarity). Interacts with MDK; this interaction promotes NCL
CC       clustering and lateral movements of this complex into lipid rafts
CC       leading to MDK internalization (By similarity). Interacts with HDGF (By
CC       similarity). {ECO:0000250|UniProtKB:P09405,
CC       ECO:0000250|UniProtKB:P19338}.
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus. Cytoplasm {ECO:0000250}.
CC       Note=Localized in cytoplasmic mRNP granules containing untranslated
CC       mRNAs. {ECO:0000250}.
CC   -!- PTM: Some glutamate residues are glycylated by TTLL8. This modification
CC       occurs exclusively on glutamate residues and results in a glycine chain
CC       on the gamma-carboxyl group (By similarity). {ECO:0000250}.
CC   -!- PTM: Symmetrically methylated by PRMT5 (By similarity).
CC       {ECO:0000250|UniProtKB:P19338}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M55022; AAA41732.1; -; Genomic_DNA.
DR   EMBL; M55015; AAA41732.1; JOINED; Genomic_DNA.
DR   EMBL; M55017; AAA41732.1; JOINED; Genomic_DNA.
DR   EMBL; M55020; AAA41732.1; JOINED; Genomic_DNA.
DR   EMBL; M22090; AAA41733.1; -; Genomic_DNA.
DR   PIR; JH0148; JH0148.
DR   SMR; P13383; -.
DR   IntAct; P13383; 4.
DR   MINT; P13383; -.
DR   STRING; 10116.ENSRNOP00000024712; -.
DR   iPTMnet; P13383; -.
DR   PhosphoSitePlus; P13383; -.
DR   jPOST; P13383; -.
DR   PaxDb; P13383; -.
DR   PRIDE; P13383; -.
DR   UCSC; RGD:3153; rat.
DR   RGD; 3153; Ncl.
DR   eggNOG; KOG0123; Eukaryota.
DR   InParanoid; P13383; -.
DR   Reactome; R-RNO-6791226; Major pathway of rRNA processing in the nucleolus and cytosol.
DR   PRO; PR:P13383; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005938; C:cell cortex; ISO:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0001651; C:dense fibrillar component; IDA:RGD.
DR   GO; GO:0001650; C:fibrillar center; IDA:RGD.
DR   GO; GO:0005730; C:nucleolus; IDA:RGD.
DR   GO; GO:0005654; C:nucleoplasm; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:1990904; C:ribonucleoprotein complex; ISS:UniProtKB.
DR   GO; GO:0005681; C:spliceosomal complex; IBA:GO_Central.
DR   GO; GO:0005509; F:calcium ion binding; IDA:RGD.
DR   GO; GO:0044547; F:DNA topoisomerase binding; ISO:RGD.
DR   GO; GO:1990631; F:ErbB-4 class receptor binding; IPI:RGD.
DR   GO; GO:0042393; F:histone binding; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0043236; F:laminin binding; IDA:RGD.
DR   GO; GO:0048027; F:mRNA 5'-UTR binding; ISO:RGD.
DR   GO; GO:0008022; F:protein C-terminus binding; ISO:RGD.
DR   GO; GO:0003723; F:RNA binding; IDA:RGD.
DR   GO; GO:0042134; F:rRNA primary transcript binding; IDA:RGD.
DR   GO; GO:0035368; F:selenocysteine insertion sequence binding; IDA:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; IDA:RGD.
DR   GO; GO:0003697; F:single-stranded DNA binding; IDA:RGD.
DR   GO; GO:0042162; F:telomeric DNA binding; ISS:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; ISO:RGD.
DR   GO; GO:0071364; P:cellular response to epidermal growth factor stimulus; ISO:RGD.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; ISO:RGD.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IMP:RGD.
DR   GO; GO:0006897; P:endocytosis; IMP:RGD.
DR   GO; GO:0097421; P:liver regeneration; IEP:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0017148; P:negative regulation of translation; ISO:RGD.
DR   GO; GO:0032755; P:positive regulation of interleukin-6 production; IMP:RGD.
DR   GO; GO:0048026; P:positive regulation of mRNA splicing, via spliceosome; IBA:GO_Central.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:1901838; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; ISO:RGD.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; IMP:RGD.
DR   GO; GO:2000232; P:regulation of rRNA processing; IDA:RGD.
DR   GO; GO:0007283; P:spermatogenesis; IEP:RGD.
DR   CDD; cd12403; RRM1_NCL; 1.
DR   CDD; cd12404; RRM2_NCL; 1.
DR   CDD; cd12405; RRM3_NCL; 1.
DR   CDD; cd12406; RRM4_NCL; 1.
DR   Gene3D; 3.30.70.330; -; 4.
DR   InterPro; IPR034230; Nucleolin_RRM1.
DR   InterPro; IPR034233; Nucleolin_RRM2.
DR   InterPro; IPR034234; Nucleolin_RRM3.
DR   InterPro; IPR034235; Nucleolin_RRM4.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   Pfam; PF00076; RRM_1; 4.
DR   SMART; SM00360; RRM; 4.
DR   SUPFAM; SSF54928; SSF54928; 4.
DR   PROSITE; PS50102; RRM; 4.
PE   1: Evidence at protein level;
KW   Acetylation; Cytoplasm; DNA-binding; Isopeptide bond; Methylation; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; RNA-binding; Ubl conjugation.
FT   CHAIN           1..713
FT                   /note="Nucleolin"
FT                   /id="PRO_0000081694"
FT   REPEAT          58..65
FT                   /note="1"
FT   REPEAT          75..82
FT                   /note="2"
FT   REPEAT          83..90
FT                   /note="3"
FT   REPEAT          91..98
FT                   /note="4"
FT   REPEAT          99..104
FT                   /note="5; truncated"
FT   REPEAT          105..112
FT                   /note="6"
FT   REPEAT          120..127
FT                   /note="7"
FT   REPEAT          128..135
FT                   /note="8"
FT   DOMAIN          311..387
FT                   /note="RRM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          397..470
FT                   /note="RRM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          489..563
FT                   /note="RRM 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          575..650
FT                   /note="RRM 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   REGION          58..135
FT                   /note="8 X 8 AA tandem repeats of X-T-P-X-K-K-X-X"
FT   COMPBIAS        143..168
FT                   /note="Asp/Glu-rich (acidic)"
FT   COMPBIAS        188..216
FT                   /note="Asp/Glu-rich (acidic)"
FT   COMPBIAS        242..275
FT                   /note="Asp/Glu-rich (acidic)"
FT   COMPBIAS        652..703
FT                   /note="Arg/Gly/Phe-rich"
FT   MOD_RES         9
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         15
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P09405"
FT   MOD_RES         16
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P09405"
FT   MOD_RES         28
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         34
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         40
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         41
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         67
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         69
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         76
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         84
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         92
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         96
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P09405"
FT   MOD_RES         99
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         102
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         106
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         109
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P09405"
FT   MOD_RES         116
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         121
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         124
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         145
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         157
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         187
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         213
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         221
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         305
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         322
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         352
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P09405"
FT   MOD_RES         360
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         371
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         381
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         402
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         405
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         409
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         448
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P09405"
FT   MOD_RES         462
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         464
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         471
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P09405"
FT   MOD_RES         480
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P09405"
FT   MOD_RES         516
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         524
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P09405"
FT   MOD_RES         566
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         575
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         580
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         583
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         594
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         622
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         649
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   MOD_RES         659
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P08199"
FT   MOD_RES         663
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P08199"
FT   MOD_RES         669
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P08199"
FT   MOD_RES         673
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P08199"
FT   MOD_RES         676
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P08199"
FT   MOD_RES         682
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P08199"
FT   MOD_RES         684
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P08199"
FT   MOD_RES         690
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P08199"
FT   MOD_RES         694
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P08199"
FT   MOD_RES         697
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P08199"
FT   MOD_RES         697
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P09405"
FT   CROSSLNK        301
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   CROSSLNK        301
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   CROSSLNK        328
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   CROSSLNK        328
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   CROSSLNK        374
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   CROSSLNK        381
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   CROSSLNK        516
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   CROSSLNK        580
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   CROSSLNK        592
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   CROSSLNK        592
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
FT   CROSSLNK        627
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P19338"
SQ   SEQUENCE   713 AA;  77147 MW;  9652B27BFD12C8EC CRC64;
     MVKLAKAGKT HGESKKMAPP PKEVEEDSED EEMSEDEDDS SGEEEVVIPQ KKGKKATTTP
     AKKVVVSQTK KAAVPTPAKK AAVTPGKKAA ATPAKKAVTP AKVVPTPGKK GAAQAKALVP
     TPGKKGAVTP AKGAKNGKNA KKEDSDEDED EEDEDDSDED EDEEDEFEPP VVKGVKPAKA
     APAAPASEDE DEEDDDDEDD DDDDEEEEEE DDSEEEVMEI TPAKGKKTPA KVVPVKAKSV
     AEEEEDDEDD EDEEEDEDEE DEEDDEDEDE EEEEEPVKAA PGKRKKEMTK QKEAPEAKKQ
     KIEGSEPTTP FNLFIGNLNP NKSVAELKVA ISELFAKNDL AAVDVRTGTN RKFGYVDFES
     AEDLEKALEL TGLKVFGNEI KLEKPKGRDS KKVRAARTLL AKNLSFNITE DELKEVFEDA
     VEIRLVSQDG RSKGIAYIEF KSEADAEKNL EEKQGAEIDG RSVSLYYTGE KGQRQERTGK
     NSTWSGESKT LVLSNLSYSA TEETLQEVFE KATFIKVPQN PHGKSKGYAF IEFASFEDAK
     EALNSCNKME IEGRTIRLEL QGPRGSPNAR SQPSKTLFVK GLSEDTTEET LKESFEGSVR
     ARIVTDRETG SSKGFGFVDF NSEEDAKAAK EAMEDGEIDG NKVTLDWAKP KGEGGFGGRG
     GGRGGFGGRG GGRGGRGGFG GRGRGGFGGR GGFRGGRGGG GDFKPQGKKT KFE
//
